Our pharmaceutical and surgical research operations are open to new ideas. As such, our operations don't limit the possibility of potential treatments by focusing on any specific area. We welcome ideas that could help us eliminate blindness worldwide. And because we are open to improving upon our existing technology, our door remains open to those leading-edge surgeons and technology companies around the world who know eye health best.

We recognize the speed in time-to-market with vision saving technology only increases when other scientists, technologists and researchers submit their ideas for the latest in surgical therapeutic tools. As such, we welcome global licenses and co-promotion agreements for marketed compounds, preclinical compounds, clinical compounds and surgical devices and technologies related to these areas of interest:

  • Cataract
  • Dry Eye
  • Glaucoma
  • Ocular allergy and inflammation
  • Ocular infections
  • Otic/Nasal
  • Refractive
  • Retina

Submit an Idea for an In-Licensing Partnership.

back to top